Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.9M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$23.4M |
| 4 |
Bilibili
BILI
|
+$21.7M |
| 5 |
Gaotu Techedu
GOTU
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$89.7M |
| 2 |
Dominion Energy
D
|
+$69.9M |
| 3 |
Cheniere Energy
LNG
|
+$63.1M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$62.8M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 15.11% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Healthcare | 12.79% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Chevron
CVX
$403B
| $1.73M | 0.11% |
23,825
-6,803
| -22% | -$672K |
|
|
AL
227
DELISTED
Air Lease Corp
AL
| $1.73M | 0.11% |
+77,900
| New | +$2.96M |
|
228
Applied Materials
AMAT
$391B
| $1.72M | 0.11% |
37,557
-13,043
| -26% | -$749K |
|
229
Clorox
CLX
$12.9B
| $1.72M | 0.11% |
+9,932
| New | +$1.64M |
|
230
AbbVie
ABBV
$468B
| $1.71M | 0.11% |
+22,461
| New | +$1.91M |
|
231
Cinemark Holdings
CNK
$4.24B
| $1.71M | 0.11% |
167,821
+123,286
| +277% | +$3.16M |
|
232
Ametek
AME
$54.9B
| $1.7M | 0.11% |
23,653
+20,653
| +688% | +$1.86M |
|
|
Y
233
DELISTED
Alleghany Corp
Y
| $1.69M | 0.11% |
3,056
+1,756
| +135% | +$1.26M |
|
234
Shopify
SHOP
$192B
| $1.67M | 0.11% |
+40,020
| New | +$1.8M |
|
235
Monster Beverage
MNST
$93.6B
| $1.67M | 0.11% |
118,444
+6,152
| +5% | +$98.9K |
|
|
EXAS
236
DELISTED
Exact Sciences
EXAS
| $1.66M | 0.1% |
28,557
-53,844
| -65% | -$4.37M |
|
237
Global Payments
GPN
$24.7B
| $1.65M | 0.1% |
11,431
-151,274
| -93% | -$27.6M |
|
238
Genuine Parts
GPC
$18.5B
| $1.64M | 0.1% |
+24,288
| New | +$2.16M |
|
239
Verizon
VZ
$205B
| $1.63M | 0.1% |
+30,387
| New | +$1.74M |
|
240
Constellium
CSTM
$3.66B
| $1.63M | 0.1% |
312,400
-788,700
| -72% | -$8.48M |
|
241
Paychex
PAYX
$44.3B
| $1.61M | 0.1% |
+25,622
| New | +$2.05M |
|
242
Nucor
NUE
$55.3B
| $1.61M | 0.1% |
+44,600
| New | +$1.98M |
|
243
Amphenol
APH
$194B
| $1.59M | 0.1% |
87,564
-172,436
| -66% | -$4.11M |
|
244
Aflac
AFL
$58.2B
| $1.59M | 0.1% |
46,566
+24,558
| +112% | +$1.12M |
|
245
Synopsys
SNPS
$76.2B
| $1.59M | 0.1% |
12,357
-31,543
| -72% | -$4.49M |
|
246
Knight Transportation
KNX
$11.7B
| $1.59M | 0.1% |
48,461
-366,825
| -88% | -$13M |
|
247
KLA
KLAC
$240B
| $1.58M | 0.1% |
110,170
+90,160
| +451% | +$1.45M |
|
248
Abbott
ABT
$202B
| $1.58M | 0.1% |
20,000
+1,635
| +9% | +$136K |
|
249
Canadian National Railway
CNI
$78.5B
| $1.57M | 0.1% |
20,171
+19,854
| +6,263% | +$1.73M |
|
250
Zimmer Biomet
ZBH
$19.3B
| $1.55M | 0.1% |
15,847
-48,382
| -75% | -$6.34M |
|
Similar funds
Steve Schonfeld's Q1 2020 Portfolio in Review
As of Q1 2020, Steve Schonfeld held 1,717 positions worth $1.59B, down 61% from $4.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $1.91B in Q1 2020, closing 624 positions and reducing 338 holdings. Its most notable exit was Vistra, an estimated $89.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt worth $30M.
- Steve Schonfeld's largest Q1 2020 buy was Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt: 3,000,000 shares worth $30M.
- Steve Schonfeld added most to Allergan plc in Q1 2020, an estimated $26.9M increase.
- Steve Schonfeld's biggest Q1 2020 reduction was Cheniere Energy, cutting an estimated $63.1M.
- Steve Schonfeld fully exited Vistra in Q1 2020, selling an estimated $89.7M.
- Steve Schonfeld's ten largest holdings make up 16% of its $1.59B portfolio in Q1 2020.
- Steve Schonfeld opened 455 new positions and closed 624 in Q1 2020.
- Steve Schonfeld's portfolio value fell 61% quarter-over-quarter to $1.59B.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.